Floatz logo

Kml-001

Platinum Responsive Malignancies

University of Maryland, BaltimorePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Platinum Responsive Malignancies cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
University of Maryland, Baltimore
Phase 1CC

Same molecule, other indications

Kml-001 is also rated in:

Non-Small Cell Lung Cancer, Small Cell Lung CancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →